These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 31573412)

  • 1. A retrospective chart review of outcomes resulting from a three-day tramadol taper for acute opioid withdrawal.
    Radcliff JA; Vellanki SC; Moore PS; Weisensell BJ; Cather JK
    J Addict Dis; 2018; 37(3-4):252-258. PubMed ID: 31573412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of cytochrome P450 2D6 inhibitors on a high-dose tramadol taper for medically supervised opioid withdrawal: a retrospective chart review.
    Stump T; Cather J; Moore PS
    J Addict Dis; 2021; 39(1):81-87. PubMed ID: 32921297
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.
    Dunn KE; Tompkins DA; Bigelow GE; Strain EC
    JAMA Psychiatry; 2017 Sep; 74(9):885-893. PubMed ID: 28700791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tramadol versus buprenorphine for the treatment of opiate withdrawal: a retrospective cohort control study.
    Tamaskar R; Parran TV; Heggi A; Brateanu A; Rabb M; Yu J
    J Addict Dis; 2003; 22(4):5-12. PubMed ID: 14723474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inpatient initiation of buprenorphine maintenance vs. detoxification: can retention of opioid-dependent patients in outpatient counseling be improved?
    Caldiero RM; Parran TV; Adelman CL; Piche B
    Am J Addict; 2006; 15(1):1-7. PubMed ID: 16449087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tramadol versus buprenorphine for the management of acute heroin withdrawal: a retrospective matched cohort controlled study.
    Threlkeld M; Parran TV; Adelman CA; Grey SF; Yu J
    Am J Addict; 2006; 15(2):186-91. PubMed ID: 16595358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital.
    Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E
    Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shortened Taper Duration after Implementation of a Standardized Protocol for Iatrogenic Benzodiazepine and Opioid Withdrawal in Pediatric Patients: Results of a Cohort Study.
    Vipond JM; Heiberger AL; Thompson PA; Huber JN
    Pediatr Qual Saf; 2018; 3(3):e079. PubMed ID: 30229191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects.
    Chawla JM; Pal H; Lal R; Jain R; Schooler N; Balhara YP
    J Opioid Manag; 2013; 9(1):35-41. PubMed ID: 23709302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel non-opioid protocol for medically supervised opioid withdrawal and transition to antagonist treatment.
    Rudolf G; Walsh J; Plawman A; Gianutsos P; Alto W; Mancl L; Rudolf V
    Am J Drug Alcohol Abuse; 2018; 44(3):302-309. PubMed ID: 28795846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid tapering in hematopoietic progenitor cell transplant recipients.
    Pederson C; Parran L
    Oncol Nurs Forum; 2000 Oct; 27(9):1371-80. PubMed ID: 11058969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of neonatal withdrawal with clonidine after long-term, high-dose maternal use of tramadol.
    O'Mara K; Gal P; Davanzo C
    Ann Pharmacother; 2010; 44(7-8):1342-4. PubMed ID: 20587741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modest opioid withdrawal suppression efficacy of oral tramadol in humans.
    Lofwall MR; Walsh SL; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2007 Oct; 194(3):381-93. PubMed ID: 17605004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid withdrawal signs and symptoms in children: frequency and determinants.
    Fisher D; Grap MJ; Younger JB; Ameringer S; Elswick RK
    Heart Lung; 2013; 42(6):407-13. PubMed ID: 24008186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.
    Bisaga A; Mannelli P; Yu M; Nangia N; Graham CE; Tompkins DA; Kosten TR; Akerman SC; Silverman BL; Sullivan MA
    Drug Alcohol Depend; 2018 Jun; 187():171-178. PubMed ID: 29674251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Tapering in Fibromyalgia Patients: Experience from an Interdisciplinary Pain Rehabilitation Program.
    Cunningham JL; Evans MM; King SM; Gehin JM; Loukianova LL
    Pain Med; 2016 Sep; 17(9):1676-85. PubMed ID: 26755658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of low-dose transdermal buprenorphine patches (5, 10, and 20 microg/h) versus prolonged-release tramadol tablets (75, 100, 150, and 200 mg) in patients with chronic osteoarthritis pain: a 12-week, randomized, open-label, controlled, parallel-group noninferiority study.
    Karlsson M; Berggren AC
    Clin Ther; 2009 Mar; 31(3):503-13. PubMed ID: 19393841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine for the management of opioid withdrawal.
    Gowing L; Ali R; White J
    Cochrane Database Syst Rev; 2000; (3):CD002025. PubMed ID: 10908521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naltrexone shortened opioid detoxification with buprenorphine.
    Umbricht A; Montoya ID; Hoover DR; Demuth KL; Chiang CT; Preston KL
    Drug Alcohol Depend; 1999 Oct; 56(3):181-90. PubMed ID: 10529020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of tramadol for acute heroin withdrawal: a comparison to clonidine.
    Sobey PW; Parran TV; Grey SF; Adelman CL; Yu J
    J Addict Dis; 2003; 22(4):13-25. PubMed ID: 14723475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.